The Canadian COVID‑19 Funded Research Database

University of Toronto

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 21 through 30 of 50 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Rapid development of antiviral compounds to fight the COVID‑19 outbreak

Sidhu, Sachdev S | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of safe and effective vaccines against COVID-19

Liu, Jun | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

Living with long-COVID. Patient experience to inform policy makers and care providers

Law, Susan K | University of Toronto | Operating Grant | $275,969

CIHR Ontario 2021

COVID-19 Variant Supplement – Engage-COVID-19: A mixed methods study of biomedical, behavioural, and psychosocial aspects of the COVID‑19 pandemic among gay, bisexual, and other men who have sex with men in Canada

Grace, Daniel | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Neutralizing Antibodies as SARS-CoV-2 Therapeutics

Rini, James M | University of Toronto | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Network – Agent-based and multi-scale mathematical modelling of COVID‑19 for assessments of sustained transmission risk and effectiveness of countermeasures

Murty, Vijayakumar | University of Toronto | Operating Grant | $100,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Kozak, Robert A | University of Toronto | Operating Grant | $44,460

CIHR Ontario 2021

Intranasal multivalent vaccines targeting COVID‑19 variants of concern

Liu, Jun | University of Toronto | Operating Grant | $499,416

CIHR Ontario 2021

Vaccine Outreach Integrating Community Engagement & Science (VOICES): Addressing COVID‑19 Vaccine Hesitancy and Promoting Uptake among Racialized Sexual and Gender Minority Populations

Newman, Peter A | University of Toronto | Operating Grant | $374,314

CIHR Ontario 2021

Defining the impact of pre-existing host immunity on SARS-CoV-2 incidence and COVID‑19 clinical outcome

Kaul, Rupert | University of Toronto | Project Grant | $489,600

CIHR Ontario 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Rapid development of antiviral compounds to fight the COVID‑19 outbreak

COVID-19 Variant Supplement – Development of safe and effective vaccines against COVID-19

Living with long-COVID. Patient experience to inform policy makers and care providers

COVID-19 Variant Supplement – Engage-COVID-19: A mixed methods study of biomedical, behavioural, and psychosocial aspects of the COVID‑19 pandemic among gay, bisexual, and other men who have sex with men in Canada

COVID-19 Variant Supplement – Neutralizing Antibodies as SARS-CoV-2 Therapeutics

COVID-19 Variant Network – Agent-based and multi-scale mathematical modelling of COVID‑19 for assessments of sustained transmission risk and effectiveness of countermeasures

COVID-19 Variant Supplement – Development of vaccine candidates and monoclonal antibodies to interrupt the spread of the novel coronavirus, COVID-19.

Intranasal multivalent vaccines targeting COVID‑19 variants of concern

Vaccine Outreach Integrating Community Engagement & Science (VOICES): Addressing COVID‑19 Vaccine Hesitancy and Promoting Uptake among Racialized Sexual and Gender Minority Populations

Defining the impact of pre-existing host immunity on SARS-CoV-2 incidence and COVID‑19 clinical outcome